Popular ADHD News and Current Events | Page 25

Popular ADHD News and Current Events, ADHD News Articles.
Sort By: Most Relevant | Most Recent
Page 25 of 25 | 1000 Results
Brain networks strengthened by closing ion channels
Yale School of Medicine and University of Crete School of Medicine researchers report in Cell April 20 the first evidence of a molecular mechanism that dynamically alters the strength of higher brain network connections involved in working memory. This discovery may help the development of drug therapies for the cognitive deficits of normal aging, and for cognitive changes in schizophrenia, bipolar disorder, or attention deficit hyperactivity disorder (ADHD). (2007-04-20)

Use of acetaminophen during pregnancy linked to ADHD in children, UCLA researchers say
A study by researchers at the UCLA Fielding School of Public Health shows that taking acetaminophen during pregnancy is associated with a higher risk in children of Attention-Deficit/Hyperactivity Disorder and Hyperkinetic Disorders. (2014-02-24)

Concerta® approved for ADHD in first European market
A new, once-daily treatment for attention deficit hyperactivity disorder (ADHD), Concerta® XL (methylphenidate HCl), has been approved in the United Kingdom, the first European Union country to license the product. Other regulatory reviews of the Janssen-Cilag medication are planned in the remainder of the European Union, and are in process in Latin America and the Asia-Pacific region. (2002-02-25)

Shire announces filing of VYVANSE for treatment of ADHD in adults
Shire plc announced today that it has submitted a supplemental New Drug Application to the US FDA for VYVANSE for the treatment of Attention Deficit Hyperactivity Disorder in adults. (2007-06-29)

Children with FASD have more severe behavioral problems than children with ADHD
Children with fetal alcohol spectrum disorders (FASD) have a high risk of psychiatric problems, including attention deficit hyperactivity disorder (ADHD). Children with FASD are often initially diagnosed with ADHD. A first-of-its-kind study shows that children with FASD have a distinct behavioural profile: significantly weaker social cognition and facial emotion-processing abilities than children with ADHD. (2009-07-16)

Computer-based program may help relieve some ADHD symptoms in children
An intensive, five-week working memory training program shows promise in relieving some of the symptoms of attention deficit hyperactivity disorder in children, a new study suggests. Researchers found significant changes for students who completed the program in areas such as attention, ADHD symptoms, planning and organization, initiating tasks and working memory. (2010-12-09)

Study reveals how ADHD drugs work in brain
Although millions depend on medications such as Ritalin to quell symptoms of attention deficit hyperactivity disorder (ADHD), scientists have struggled to pinpoint how the drugs work in the brain. But new work at the University of Wisconsin-Madison is now starting to clear up some of the mystery. (2006-06-26)

Tonsillectomy associated with improved sleep and behavior in children with breathing disorders
Children diagnosed with sleep-disordered breathing appear to sleep better and have improved behavior following removal of their tonsils and adenoids, according to a report in the October issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. (2007-10-15)

Drug being used to improve cognition affects dopamine, suggesting potential for abuse
Preliminary research in healthy men suggests that the narcolepsy drug modafinil, increasingly being used to enhance cognitive abilities, affects the activity of dopamine in the brain in a way that may create the potential for abuse and dependence, according to a study in the March 18 issue of JAMA. (2009-03-17)

Short-term use of amphetamines can improve ADHD symptoms in adults
Giving amphetamines to adults with attention deficit hyperactivity disorder (ADHD) can help them control their symptoms, but the side effects mean that some people do not manage to take them for very long. These conclusions were drawn by a team of five researchers working at Girona and Barcelona universities in Spain, and published in a new Cochrane Systematic Review. (2011-07-27)

Medications aren't affecting brain size in children with ADHD
Although children with attention-deficit/hyperactivity disorder (ADHD) have slightly smaller brains than children without the disorder, medications used to treat ADHD aren't causing this apparent difference in brain size and do not appear to be affecting normal brain development, according to the largest brain imaging study yet conducted on children with the disorder. (2002-10-08)

Gene predicts better outcome as cortex normalizes in teens with ADHD
Brain areas that control attention were thinnest in children with attention deficit hyperactivity disorder who carried a particular version of a gene. However, the areas, on the right side of the brain's cortex, normalized during the teen years, coinciding with clinical improvement. While the gene variant increased risk for ADHD, it also predicted better clinical outcomes and higher IQ than two other common versions of the same gene in youth with ADHD. (2007-08-06)

Cost control measures limit patient and physician choice in psychotropic medications
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University. (2007-03-01)

Shire presents new scientific data on ADHD treatments at National Psychiatric Scientific Meeting
Shire plc, the global specialty biopharmaceutical company will present key scientific data on its attention deficit hyperactivity disorder treatments lisdexamfetamine dimesylate and investigational nonscheduled guanfacine extended release, at a national scientific meeting of psychiatrists to be held May 16-21 in San Francisco. A summary of the key clinical data is provided. (2009-05-18)

Mothers of children with autism less likely to have taken iron supplements
Mothers of children with autism are significantly less likely to report taking iron supplements before and during their pregnancies than the mothers of children who are developing normally, a study by researchers with the UC Davis MIND Institute has found. (2014-09-22)

News tips from the Journal of Neuroscience
The following articles are featured in the July 9 issue of the Journal of Neuroscience: Dopamine transporter efflux in ADHD; Learning-induced gray-matter plasticity; Preventing programmed cell death in vivo; and Neurological effects of folate deficiency. (2008-07-08)

Research-based exercise program turning preschoolers into 'Fit Kids'
Reuben Brough is running around a gym at a local youth center waving his hands in the air and screeching like a cheetah. A stream of children is in hot pursuit of him and four other students from the University of Vermont who implore the preschoolers to 'catch the cheetah.' It looks like total chaos, but there's a method to the madness, which is really a highly structured, research-based fitness program called Children and Teachers (CATs) on the Move. (2016-05-02)

St. John's wort does not appear effective for treating ADHD in children and teens
Children and teens with attention-deficit/hyperactivity disorder who were treated with the herb St. John's wort did not have any greater improvement in ADHD symptoms compared to those who received placebo, according to a study in the June 11 issue of JAMA. (2008-06-10)

Bedroom access to screen-based media may contribute to sleep problems in boys with autism, MU researchers find
Having bedroom access to television, computers or video games is linked to less sleep in boys with autism spectrum disorder, a team of University of Missouri researchers found. (2013-11-19)

Genetic predisposition to liking amphetamine reduces risk of schizophrenia and ADHD
Genetic variants associated with enjoying the effects of d-amphetamine -- the active ingredient in Adderall -- are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder, report scientists from the University of Chicago in the Proceedings of the National Academy of Sciences on April 7. The results support a long-standing hypothesis that dopamine, the neurotransmitter connected with the euphoric effects of amphetamine, is related to schizophrenia and attention deficit hyperactivity disorder. (2014-04-07)

Estimated costs of environmental disease in children at $76.6 billion per year
In three new studies published in the May issue of the journal Health Affairs, Mount Sinai School of Medicine researchers reveal the staggering economic impact of toxic chemicals and air pollutants in the environment, and propose new legislation to mandate testing of new chemicals and also those already on the market. (2011-05-04)

Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies
Shire PLC announced the availability of INTUNIV in pharmacies nationwide for the treatment of ADHD in children and adolescents ages 6-17. INTUNIV, a once-daily formulation of guanfacine, is the first and only nonscheduled alpha-2A receptor agonist approved for the treatment of ADHD. In clinical trials, INTUNIV provided significant efficacy across the spectrum of ADHD symptoms that can be disruptive, such as being easily distracted, interrupting others, running around excessively, arguing with adults, and losing temper. (2009-11-09)

Teens' mental health affects how long they stay in school, new study shows
Queen's University researcher Steven Lehrer has won a prestigious international award in recognition of his contributions to health economics. A professor in Queen's School of Policy Studies and Department of Economics, Dr. Lehrer shares the RAND Corporation's Victor R. Fuchs Research Award with Jason Fletcher of Yale University. Their prize-winning paper, recently published in the journal Forum for Health Economics & Policy, examines the effects of adolescent health on educational outcomes. (2009-11-12)

Using brain connectivity growth charting in youth to identify attention problems
Pediatricians routinely use growth charts to measure patients' height, weight and head circumference to look for abnormalities. What about using growth charting to examine maturation of functional networks in the brain to look for neurocognitive abnormalities such as attention impairment? (2016-04-13)

Brain shrinkage in ADHD not caused by medications
A 10-year study by NIMH scientists has found that brains of children and adolescents with ADHD are 3-4 percent smaller than those of children who don't have the disorder - and that medication treatment is not the cause. This first major study to scan previously never-medicated patients found (2002-10-08)

Placebo effects in caregivers may change behavior of children with ADHD
Stimulant medications, such as Ritalin and Adderall, are the accepted treatment to stem hyperactivity in children with attention deficit-hyperactive disorder and improve their behavior. Now a recent review of research by University at Buffalo pediatric psychologists suggests that such medication, or the assumption of medication, may produce a placebo effect -- not in the children, but in their teachers, parents or other adults who evaluate them. (2009-06-29)

New study in pediatrics shows single dose of ADHD medication lasts entire school day
A new University at Buffalo study published in the December issue of Pediatrics comparing the effectiveness over time of Adderall and Ritalin -- two drugs for attention- deficit/hyperactivity disorder (ADHD) -- shows that a single dose of Adderall is effective for a full school day. (1999-12-05)

Scientists map maturation of the human brain
For the first time, scientists have mapped the progressive maturation of the human brain in childhood and adolescence. In other studies, they have made advances in understanding during adolescence the effects of stress, nicotine, and alcohol. (2003-11-08)

Punishment can enhance performance, Nottingham academics find
A study led by researchers from the University's School of Psychology, published recently in the Journal of Neuroscience, has shown that punishment can act as a performance enhancer in a similar way to monetary reward. (2013-03-13)

Improved Ritalin™ Offers Smaller Doses And Fewer Side Effects
A new more effective form of the drug Ritalin ™ that produces fewer side effects and has the potential to be used in anticocaine therapy could soon be available. Commonly prescribed to treat Attention Deficit/Hyperactivity Disorder (ADHD), Ritalin is prescribed to an estimated 1.5 million U.S. elementary and secondary students. (1999-03-23)

Capsules effective in treating acute manic and mixed episodes of Bipolar I Disorder
Shire Pharmaceuticals Inc. has announced that University of North Carolina at Chapel Hill researchers studied the efficacy of carbamazepine extended-release capsules (CBZ-ERC, Equetro) in patients with manic or mixed episodes of Bipolar I Disorder over six months. Data from this open label study was presented by UNC researchers last week at the 18th annual US Psychiatric and Mental Health Congress in Las Vegas. (2005-11-16)

Smokers Use Nicotine To Manage Depression, Other Disorders
More studies show that hard core smokers may be using nicotine to manage depression, ADHD, anxiety or bulimia. People with these conditions or co-factors often use nicotine to help manage their symptoms. Treat the disorders first or simultaneously, says U-M study. (1997-08-06)

Writing in cursive with your eyes only
A new technology described in the paper published online on July 26 in Current Biology, a Cell Press publication, might allow people who have almost completely lost the ability to move their arms or legs to communicate freely, by using their eyes to write in cursive. The eye-writing technology tricks the neuromuscular machinery into doing something that is usually impossible: to voluntarily produce smooth eye movements in arbitrary directions. (2012-07-26)

How do ADHD medications work?
There is a swirling controversy regarding the suspicion that medications prescribed for the treatment of ADHD (attention-deficit/hyperactivity disorder) primarily act to control disruptive behavior as opposed to having primary effects on the ability to attend to the environment. Thus, there is a continued need to better understand the neural basis of ADHD medication effects. (2013-10-16)

Nonprescription use of Ritalin linked to adverse side effects, UB study finds
New research from the University at Buffalo Research Institute on Addictions that explored the potential side effects of the stimulant drug Ritalin on those without ADHD showed changes in brain chemistry associated with risk-taking behavior, sleep disruption and other undesirable effects. (2017-05-15)

Imaging children with ADHD
Children with attention deficit-hyperactivity disorder (ADHD) may have significantly altered levels of important neurotransmitters in the frontal region of the brain, according to a study from the Journal of Neuropsychiatry and Clinical Neurosciences to be presented at the American Medical Association Advances in Neurology Media Briefing in New York Dec. 4. In the study, children with ADHD had a two-and-half-fold increased level of glutamate, an excitatory brain chemical that can be toxic to nerve cells. (2003-12-04)

ADHD medicine affects the brain's reward system
A group of scientists from the University of Copenhagen has created a model that shows how some types of ADHD medicine influence the brain's reward system. The model makes it possible to understand the effect of the medicine and perhaps in the longer term to improve the development of medicine and dose determination. The new research results have been published in the Journal of Neurophysiology. (2012-11-09)

Mount Sinai researcher finds timing of ADHD medication affect academic progress
A team of researchers led by an epidemiologist at Mount Sinai School of Medicine and University of Iceland has found a correlation between the age at which children with attention-deficit/hyperactivity disorder begin taking medication, and how well they perform on standardized tests, particularly in math. (2012-06-25)

Gene variants implicated ADHD identify attention and language deficits general population
Are deficits in attention limited to those with attention-deficit/hyperactivity disorder or is there a spectrum of attention function in the general population? The answer to this question has implications for psychiatric diagnoses and perhaps for society, broadly. (2014-10-15)

Recovery from childhood ADHD may depend on the pattern of brain development
Some people grow out of their childhood attention-deficit/hyperactivity disorder (ADHD) and some don't. In fact, around 50 percent of individuals diagnosed as children continue to suffer from ADHD as adults. (2013-10-15)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.